Citigroup Inc Biolife Solutions Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Citigroup Inc holds 45,980 shares of BLFS stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,980

Previous 25,930 77.32%

Holding current value

$1.15 Million

Previous $555,000 107.21%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.19 - $26.52 $384,759 - $531,726	20,050 Added 77.32%	45,980 $1.15 Million
Q2 2024 Aug 12, 2024	BUY	$15.14 - $22.99 $28,387 - $43,106	1,875 Added 7.79%	25,930 $555,000
Q1 2024 May 10, 2024	BUY	$15.35 - $18.82 $53,955 - $66,152	3,515 Added 17.11%	24,055 $446,000
Q4 2023 Feb 09, 2024	BUY	$8.99 - $16.86 $68,126 - $127,765	7,578 Added 58.46%	20,540 $333,000
Q3 2023 Nov 09, 2023	SELL	$10.81 - $22.96 $189,823 - $403,177	-17,560 Reduced 57.53%	12,962 $179,000
Q2 2023 Aug 10, 2023	BUY	$17.19 - $24.34 $259,723 - $367,753	15,109 Added 98.03%	30,522 $674,000
Q1 2023 May 11, 2023	SELL	$17.67 - $26.07 $88,420 - $130,454	-5,004 Reduced 24.51%	15,413 $335,000
Q4 2022 Feb 09, 2023	BUY	$16.95 - $25.07 $73,207 - $108,277	4,319 Added 26.83%	20,417 $371,000
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $37,009 - $67,497	2,528 Added 18.63%	16,098 $366,000
Q2 2022 Aug 10, 2022	SELL	$10.54 - $24.2 $119,671 - $274,766	-11,354 Reduced 45.55%	13,570 $187,000
Q1 2022 May 12, 2022	BUY	$20.81 - $37.29 $144,358 - $258,680	6,937 Added 38.57%	24,924 $567,000
Q4 2021 Feb 10, 2022	BUY	$32.99 - $58.55 $102,203 - $181,387	3,098 Added 20.81%	17,987 $670,000
Q3 2021 Nov 10, 2021	BUY	$42.03 - $60.5 $625,784 - $900,784	14,889 New	14,889 $630,000

Others Institutions Holding BLFS

# of Institutions

199

Shares Held

45M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.07B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account